Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0A9NE
|
||||
Former ID |
DNC011381
|
||||
Drug Name |
2-(3,4-Dihydroxy-benzyl)-7-hydroxy-chromen-4-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [525506] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H12O5
|
||||
Canonical SMILES |
C1=CC(=C(C=C1CC2=CC(=O)C3=C(O2)C=C(C=C3)O)O)O
|
||||
InChI |
1S/C16H12O5/c17-10-2-3-12-14(19)8-11(21-16(12)7-10)5-9-1-4-13(18)15(20)6-9/h1-4,6-8,17-18,20H,5H2
|
||||
InChIKey |
AERADEZJMNEWMZ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Aldose reductase | Target Info | Inhibitor | [525506] | |
NetPath Pathway | IL1 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.